Yang Liang
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
-
- Traditional Chinese Medicine Analysis
Papers in
- Hematology 35
- Acute Myeloid Leukemia Research 19
- Multiple Myeloma Research and Treatments 11
- Chronic Myeloid Leukemia Treatments 6
-
- Protein Degradation and Inhibitors 7
- Co-authors
- Robert Peter Gale (18 shared papers)Ping Liu (2 shared papers)Guang‐Biao Zhou (2 shared papers)Fang Xu (1 shared paper)Chen Zhu (1 shared paper)Jian‐Hua Mao (1 shared paper)Sai-Juan Chen (1 shared paper)Lan Wang (1 shared paper)
- Journals
- Blood (16 papers)Leukemia (11 papers)British Journal of Haematology (3 papers)Proceedings of the National Academy of Sciences (2 papers)Hematological Oncology (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Yang Liang
63 papers receiving 1.8k citations
Yang Liang's Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 411
- Complementary and alternative medicine 168
- Pharmacology 148
- Infectious Diseases 206
- Molecular Biology 810
Countries citing papers authored by Yang Liang
This map shows the geographic impact of Yang Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Liang more than expected).
Fields of papers citing papers by Yang Liang
This network shows the impact of papers produced by Yang Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Liang. The network helps show where Yang Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dissection of mechanisms of Chinese medicinal formula Realgar- Indigo naturalis as an effective treatment for promyelocytic leukemia Hit paper breakdown → | 2008 | 647 |
| 2 | 2020 | 181 | |
| 3 | 2011 | 104 | |
| 4 | 2012 | 86 | |
| 5 | 2021 | 81 | |
| 6 | 2021 | 64 | |
| 7 | 2020 | 64 | |
| 8 | 2019 | 60 | |
| 9 | 2009 | 60 | |
| 10 | 2018 | 59 | |
| 11 | 2019 | 51 | |
| 12 | 2022 | 44 | |
| 13 | 2020 | 38 | |
| 14 | 2022 | 21 | |
| 15 | 2021 | 19 | |
| 16 | 2023 | 18 | |
| 17 | 2011 | 15 | |
| 18 | 2021 | 15 | |
| 19 | 2019 | 14 | |
| 20 | 2021 | 13 |
About Yang Liang
Yang Liang is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 70 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Multiple Myeloma Research and Treatments (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Protein Degradation and Inhibitors (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Hematology (411 citations), Complementary and alternative medicine (168 citations), Pharmacology (148 citations), Infectious Diseases (206 citations) and Molecular Biology (810 citations). Yang Liang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Robert Peter Gale, Ping Liu, Guang‐Biao Zhou, Fang Xu, Chen Zhu, Jian‐Hua Mao, Sai-Juan Chen, Lan Wang, Bingshun Wang and Huan Li. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, Proceedings of the National Academy of Sciences and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.